Two states sue cord blood company over misleading claims
Two states are suing a major cord blood storage company, claiming it misled parents about the benefits of saving their newborn's stem cells.
Mar 26, 2026
0
4
MeSH tree: A15.145.300
Two states are suing a major cord blood storage company, claiming it misled parents about the benefits of saving their newborn's stem cells.
Mar 26, 2026
0
4
Babies born between 2003 and 2006 were exposed to many more "forever chemicals" before birth than scientists previously understood, according to new research published in Environmental Science & Technology.
Feb 18, 2026
0
18
Researchers have identified a protein pattern that, already at birth, looks markedly different in those who later go on to develop type 1 diabetes. The findings show that a combination of several factors during pregnancy ...
Jan 28, 2026
0
12
Scientists from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago and colleagues identified several proteins from the umbilical cord blood of preterm newborns that signal ...
Jun 20, 2025
0
17
Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, has invented a new cell therapy that shows strong promise ...
May 23, 2025
0
63
Northwestern Medicine investigators have discovered how proteins expressed in umbilical cord blood at birth evolve during gestational development and could serve as biomarkers to inform new precision care strategies for infants ...
Feb 17, 2025
0
31
Some private UK biobanks may be misleading expectant parents about the value of storing umbilical cord blood to treat life-threatening diseases that may arise in their child in the future, reveals an investigation by The ...
Jul 24, 2024
0
50
An alternative method of transferring blood cells to weakened newborns through their umbilical cord does not carry long-term neurodevelopmental risks compared to standard practice, a recent study found. The research will ...
May 3, 2024
0
39
A team led by researchers from Department of Hematology and Department of Molecular Pathology, Singapore General Hospital (SGH) have developed a platform to harness and enhance the innate ability of white blood cells from ...
Jul 27, 2023
0
44
The U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic cord blood-based cell therapy, to cut the risk of infection in patients with blood cancer following a myeloablative ...
Apr 24, 2023
0
53